CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

UTI Healthcare Fund-Reg(G)

very highequitypharma & health care
286.23 1.60(0.56%) NAV as on 11 Dec 2025
-0.89 % 1 M
-1.23 % 1 Y
23.83 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.25

As on 30 Nov, 2025
age-icon Age :

20 yrs 4 m

Since 01 08 ,2005
exit_load Exit Load :

1%

aum AUM :

1,126.13 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

7.49

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Kamal Gada

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2025
Others 1.25 %
Equity 98.75 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.76 %
Ajanta Pharma Ltd.6.48 %
Lupin Ltd.5.91 %
Glenmark Pharmaceuticals Ltd.4.06 %
Dr. Reddy's Laboratories Ltd.3.74 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs76.10
Hospital & Healthcare Services21.24
Business Support1.04
Medical Equipment/Supplies/Accessories0.37
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)139.38157.00143.40223.40268.23
Net Assets(Rs Crores) (as on 31-Mar-2025) 618.13 776.23 654.50 947.26 1042.04
Scheme Returns(%)(Absolute)76.1912.06-8.8155.5418.69
B'mark Returns(%)(Absolute)NANANANANA
Category Rank35/7550/7568/7621/905/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

UTI Healthcare Fund-Reg(G)Very HighEquity286.231.60(0.56%)NAV As on 12 Dec, 202501-Aug-2005Inception Date1,126.13AUM In Cr.-1.23%1Y23.83%3Y15.73%5Y17.89%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity424.482.27(0.54%)NAV As on 12 Dec, 202514-Jul-1999Inception Date4,130.76AUM In Cr.-1.71%1Y23.41%3Y17.27%5Y15.96%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.430.02(0.06%)NAV As on 12 Dec, 202528-Dec-2015Inception Date1,338.85AUM In Cr.-1.03%1Y21.78%3Y15.94%5Y11.81%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity39.480.22(0.55%)NAV As on 12 Dec, 202530-Nov-2018Inception Date3,178.53AUM In Cr.-5.16%1Y21.01%3Y16.21%5Y21.55%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.